Skip to main content
Fig. 2 | Trials

Fig. 2

From: Comparing the effectiveness of magnesium oxide and naldemedine in preventing opioid-induced constipation: a proof of concept, single institutional, two arm, open-label, phase II, randomized controlled trial: the MAGNET study

Fig. 2

Study schedule. All objectives will be compared between magnesium oxide and naldemedine. BSFS Bristol Stool Form Scale, CSS Constipation Scoring System, JPAC-QOL Japanese version of Patient Assessment of Constipation Quality of Life questionnaire, PAC-SYM Patient Assessment of Constipation Symptoms, SBMs Spontaneous bowel movements, SF-36 36-item Short Form Health Survey

Back to article page

Trials

ISSN: 1745-6215